Clinical Trial Update: A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™ [Phase 1]

View source ↗

Summary

Phase 1 study of escalating-dose, multi-prime R21/Matrix-M malaria vaccine is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria
• Malaria

Drugs mentioned

• R21/Matrix-M malaria vaccine (R21/Matrix-M malaria vaccine)

Snippet

Sponsor: University of Oxford | Conditions: Malaria,Falciparum | Phase 1 | Status: ACTIVE_NOT_RECRUITING